Citation Impact
Citing Papers
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence
2006 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
Infective Endocarditis
2005 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Adults with genetic syndromes and cardiovascular abnormalities: clinical history and management
2008
Revised diagnostic criteria for the Marfan syndrome
1996 Standout
RISK FACTORS FOR INFECTIVE ENDOCARDITIS
1993
Infective Endocarditis in Adults
2001
Neuropathology of mitral valve prolapse in man and cardiopulmonary bypass (CPB) surgery in adolescent Yorkshire pigs
2000 StandoutNobel
Relation between severity of mitral regurgitation and prognosis of mitral valve prolapse: Echocardiographic follow-up study
1996
Clinical and Genetic Features of Ehlers–Danlos Syndrome Type IV, the Vascular Type
2000 Standout
Natural history of cardiovascular manifestations in Marfan syndrome
2001
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
2005 Standout
Association of aortic dilation with regurgitant, stenotic and functionally normal bicuspid aortic valves
1992
Prevalence and correlates of mitral regurgitation in a population-based sample (the Strong Heart Study)∗∗The views expressed in this study are those of the authors and do not necessarily reflect those of the Indian Health Service.
2001
Cushing's syndrome
2015 Standout
Incidence of Aortic Complications in Patients With Bicuspid Aortic Valves
2011
Percutaneous Repair or Surgery for Mitral Regurgitation
2011 Standout
Exercise Standards for Testing and Training
2013 Standout
Immune mechanisms in medium and large-vessel vasculitis
2013
Changes in size of ascending aorta and aortic valve function with time in patients with congenitally bicuspid aortic valves
2003
Progress toward a global understanding of infective endocarditis
2002
The bicuspid aortic valve: an integrated phenotypic classification of leaflet morphology and aortic root shape
2008
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
2009 Standout
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Diameters of the thoracic aorta throughout life as measured with helical computed tomography
2002
A prospective longitudinal evaluation of pregnancy in the Marfan syndrome
1995
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Myxoid heart disease: An assessment of extravalvular cardiac pathology in severe mitral valve prolapse
1992
Ehlers-Danlos syndromes: Revised nosology, Villefranche, 1997
1998 Standout
The Bicuspid Aortic Valve
2005
Reduced penetrance and variable expressivity of familial thoracic aortic aneurysms/dissections
1998
Guidelines for Performing a Comprehensive Transesophageal Echocardiographic Examination: Recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists
2013
Familial thoracic aortic dilation and bicommissural aortic valve: A prospective analysis of natural history and inheritance
2007
Care of Girls and Women with Turner Syndrome: A Guideline of the Turner Syndrome Study Group
2006
Right Ventricular Outflow Tract Reconstruction in Ross Patients: Does the Homograft Fare Better?
2008
Acute Stressors and Cortisol Responses: A Theoretical Integration and Synthesis of Laboratory Research.
2004 Standout
Mechanisms of Recurrent Aortic Regurgitation After Aortic Valve Repair
2009
Life expectancy in the Marfan syndrome
1995
Coronary Artery Z Score Regression Equations and Calculators Derived From a Large Heterogeneous Population of Children Undergoing Echocardiography
2008
Appetite suppressants and valvular heart disease in a population-based sample: the HyperGEN study
2002
Lack of Evidence of an Association between Mitral-Valve Prolapse and Stroke in Young Patients
1999
Myocarditis
2011 Standout
The changing pattern of infective endocarditis in childhood
1991
Effect of Beta-Blockade on Ascending Aortic Dilatation in Children With the Marfan Syndrome
2006
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
A Comparison of Echocardiography and Magnetic Resonance Imaging in Cardiovascular Screening of Adults with Turner Syndrome
2004
The double-orifice technique as a standardized approach to treat mitral regurgitation due to severe myxomatous disease: surgical technique
2000
Chronic β-blocker therapy improves outcome and reduces treatment costs in chronic type B aortic dissection
2001
Coexistence of mitral valve prolapse in a consecutive group of 528 patients with hypertrophic cardiomyopathy assessed with echocardiography
1992
Aortopathy Is Prevalent in Relatives of Bicuspid Aortic Valve Patients
2009
Angiotensin II Blockade and Aortic-Root Dilation in Marfan's Syndrome
2008
Burden of valvular heart diseases: a population-based study
2006 Standout
The incidence of congenital heart disease
2002 Standout
Time Course of Aortic Valve Function and Root Dimensions After Subcoronary Ross Procedure for Bicuspid Versus Tricuspid Aortic Valve Disease
2001
Task Force on Sudden Cardiac Death of the European Society of Cardiology
2001
Are Marfan Syndrome and Marfanoid Patients Distinguishable on Long-Term Follow-Up?
2007
The American Association for Thoracic Surgery consensus guidelines on bicuspid aortic valve–related aortopathy: Full online-only version
2018
Long-term outcomes after autograft versus homograft aortic root replacement in adults with aortic valve disease: a randomised controlled trial
2010
Prevalence of Cardiovascular Disease and Diabetes Mellitus in Residents of Rochester, Minnesota
1990
Echocardiographic reference values for aortic root size: The Framingham Heart Study
1995
Surgical treatment of the dilated ascending aorta: when and how?
1999
Long-term follow-up of patients after coarctation of the aorta repair
2002
Hypertrophic Cardiomyopathy
2002 Standout
Natural history of the asymptomatic/minimally symptomatic patient with severe mitral regurgitation secondary to mitral valve prolapse and normal right and left ventricular performance
1994
Aortic annulus evaluation in transcatheter aortic valve implantation
2010
Prevalence of aortic root dilation in the Ehlers-Danlos syndrome
2002
Accuracy of Transthoracic Echocardiography for the Measurement of the Ascending Aorta: Comparison With Transesophageal Echocardiography
2010
Infective Endocarditis: Rationale for Revised Guidelines for Antibiotic Prophylaxis
2009
Prevalence and correlates of mitral valve prolapse in a population-based sample of American Indians: the strong heart study
2001
Reference values for echocardiographic measurements in urban and rural populations of differing ethnicity: The Strong Heart Study
2001
Prevalence of Diagnosed Atrial Fibrillation in Adults
2001 Standout
Pregnancy Outcome and Mitral Valve Prolapse
1994
Rationale and design of a randomized clinical trial of β-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome
2007
Sudden death in mitral regurgitation due to flail leaflet
1999
Spontaneous Dissection of the Carotid and Vertebral Arteries
2001 Standout
Infective endocarditis
2004 Standout
Incidence and Outcomes of Acute Lung Injury
2005 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Cardiovascular, neuroendocrine, and monoaminergic responses to psychological stressors: Possible differences between remitted panic disorder patients and healthy controls
1996
Recommendations for chamber quantification☆
2006 Standout
Prevalence and Clinical Outcome of Mitral-Valve Prolapse
1999
Prevalence and correlates of aortic regurgitation in american indians: the Strong Heart Study
2000
Interpretation of echocardiographic measurements: A call for standardization
2000
Myocarditis
2009 Standout
Are high-velocity tricuspid and pulmonary regurgitation endocarditis risk substrates?
1998
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Prevalence and Clinical Significance of Aortic Root Dilation in Highly Trained Competitive Athletes
2010
Genetic Basis of Thoracic Aortic Aneurysms and Dissections: Focus on Smooth Muscle Cell Contractile Dysfunction
2008
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Prevention of Bacterial Endocarditis
1997
Risk of Stroke With Mitral Valve Prolapse in Population-Based Cohort Study
1995
Diagnosis and management of aortic dissection Task Force on Aortic Dissection, European Society of Cardiology
2001
Midterm Results of the Ross Procedure Preserving the Patient’s Aortic Root
2003
Familial Thoracic Aortic Aneurysms and Dissections
2001
Relations of Left Ventricular Mass to Demographic and Hemodynamic Variables in American Indians
1997
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Scoliosis and Fractures in Young Ballet Dancers
1986 Standout
Relations of Stroke Volume and Cardiac Output to Body Composition
2001
Aortic root dilatation in young men with normally functioning bicuspid aortic valves
1999
Failure to Prevent Progressive Dilation of Ascending Aorta by Aortic Valve Replacement in Patients With Bicuspid Aortic Valve: Comparison With Tricuspid Aortic Valve
2003
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Prevention of bacterial endocarditis. Recommendations by the American Heart Association
1997
Identification of a Chromosome 11q23.2-q24 Locus for Familial Aortic Aneurysm Disease, a Genetically Heterogeneous Disorder
2001
Treatment of Aortic Disease in Patients With Marfan Syndrome
2005
Stroke Volume/Pulse Pressure Ratio and Cardiovascular Risk in Arterial Hypertension
1999
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Echocardiographic assessment of mitral valve size in obstructive hypertrophic cardiomyopathy. Anatomic validation from mitral valve specimen.
1993
Mutations in Transforming Growth Factor-β Receptor Type II Cause Familial Thoracic Aortic Aneurysms and Dissections
2005
Aortic Root Dilatation in Patients With Spontaneous Cervical Artery Dissection
1997
Mapping of Familial Thoracic Aortic Aneurysm/Dissection With Patent Ductus Arteriosus to 16p12.2–p13.13
2005
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Effect of Hypertension on Aortic Root Size and Prevalence of Aortic Regurgitation
1996
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
Hypomastia and Mitral-Valve Prolapse
1983
Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome
2005
The Marfan Syndrome
2000
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Cerebral Ischemic Events After Diagnosis of Mitral Valve Prolapse
2003
Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: hypertrophic cardiomyopathy, long-QT syndrome, and marfan syndrome : A statement for healthcare professionals from the councils on clinical cardiology, cardiovascular disease in the young, and basic science, american heart association
1998
Progression of Aortic Dilatation and the Benefit of Long-Term β-Adrenergic Blockade in Marfan's Syndrome
1994
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome
2006 StandoutScience
Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises
2003 Standout
Mapping a Locus for Familial Thoracic Aortic Aneurysms and Dissections ( TAAD2 ) to 3p24–25
2003
Works of Randi Kramer-Fox being referenced
In vivo mitral valve morphology and motion in mitral valve prolapse
1994
Time-motion reconstruction of mitral leaflet motion from two-dimensional echocardiography in mitral valve prolapse
1991
Cost-effectiveness of infective endocarditis prophylaxis for mitral valve prolapse with or without a mitral regurgitant murmur
1994
Severe mitral regurgitation due to mitral valve prolapse: risk factors for development, progression, and need for mitral valve surgery
2000
Prognostic significance of the pattern of aortic root dilation in the Marfan syndrome
1993
Two-dimensional echocardiographic aortic root dimensions in normal children and adults
1989
Phenotypic features and impact of Beta blocker or calcium antagonist therapy on Aortic lumen size in the Marfan syndrome
1999
Natural history of mitral valve prolapse
1995
Mitral valve dimensions and motion and familial transmission of mitral valve prolapse with and without mitral leaflet billowing
1988
Comparison of cardiovascular and skeletal features of primary mitral valve prolapse and Marfan syndrome
1989
Comparison of mitral valve dimensions and motion in mitral valve prolapse with severe mitral regurgitation to uncomplicated mitral valve prolapse and to mitral regurgitation without mitral valve prolapse
1988
Mitral valve prolapse and infective endocarditis
1987
Complex arrhythmias in mitral regurgitation with and without mitral valve prolapse: Contrast to arrhythmias in mitral valve prolapse without mitral regurgitation
1985
Complications of mitral valve prolapse
1986
Contrasting patterns of autonomic dysfunction in patients with mitral valve prolapse and panic attacks
1987
Diagnosis and classification of severity of mitral valve prolapse: Methodologic, biologic, and prognostic considerations
1987
Relation between clinical features of the mitral prolapse syndrome and echocardiographically documented mitral valve prolapse
1986
ASSOCIATION OF MITRAL-VALVE PROLAPSE WITH LOW BODY-WEIGHT AND LOW BLOOD PRESSURE
1982
Mitral valve dimensions and motion in Marfan patients with and without mitral valve prolapse. Comparison to primary mitral valve prolapse and normal subjects.
1989